Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Anushka Bakshi

- PMLiVE

Oxford Biomedica taps Microsoft to progress gene therapy delivery tech

Will develop in silico models and novel algorithms

- PMLiVE

Celgene’s Abraxane fails pancreatic cancer trial

Abraxane failed to show improvement in disease-free survival

- PMLiVE

NCI head Sharpless named as interim FDA chief

The search for a permanent replacement is still ongoing

- PMLiVE

NICE partially clears Darzalex combo in blood cancer

Approved in second-line use under  CDF

- PMLiVE

Brexit deal defeated again, crucial no-deal vote awaits

UK pharma urges no-deal to be ruled out

01000010 01101001 01101110 01100001 01110010 01111001

Success and failure is a binary outcome

- PMLiVE

Bedrock keep it in the family

Recent filming project really is a family affair

Bedrock Healthcare Communications

Graduation day is celebrated by Lucid’s third Futures Academy cohort

Lucid’s Futures Academy is proud to release its most recent cohort of graduates into the business for the first of their two rotations.The Futures Academy begins with an eight-week intensive...

Lucid Group Communications Limited

- PMLiVE

Trump budget targets rebates, out-of-pocket costs

Biotech sector welcomes end to rebates, but worries about Medicare cuts

- PMLiVE

Optimism on Orkambi in England as talks to resume

Scotland's deal puts pressure on NHS England and NICE

AstraZeneca AZ

AZ signs $20m deal with Seres for microbiome project

Shares in Seres shot up 25% after the deal was announced

- PMLiVE

23andMe to offer type 2 diabetes testing kit

New report is powered by data from the company’s customers

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links